Cargando…

Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles

PURPOSE: Conventional chemotherapy is hampered by the presence of breast cancer stem cells (BCSCs). It is crucial to eradicating both the bulky breast cancer cells and BCSCs, using a combination of conventional chemotherapy and anti-CSCs drugs. However, the synergistic ratio of drug combinations can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jie, Liu, Junjie, Xie, Fangyuan, Lu, Ying, Yin, Chuan, Shen, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884979/ https://www.ncbi.nlm.nih.gov/pubmed/32063706 http://dx.doi.org/10.2147/IJN.S230376

Ejemplares similares

GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
por: Li, Kaichun, et al.
Publicado: (2021)

Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010)

Robust aptamer–polydopamine-functionalized M-PLGA–TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy
por: Xu, Guojun, et al.
Publicado: (2016)

Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir
por: Alkholief, Musaed, et al.
Publicado: (2019)

Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells
por: Wang, Qin, et al.
Publicado: (2021)

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
por: McCall, Rebecca L., et al.
Publicado: (2013)

Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment
por: Chen, Xiao-ping, et al.
Publicado: (2019)

A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls
por: Daraei, Bahram, et al.
Publicado: (2017)

The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
por: Gruber, Martina, et al.
Publicado: (2019)

Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies
por: Gaonkar, Raghuvir H., et al.
Publicado: (2017)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
por: Rafiei, Pedram, et al.
Publicado: (2017)

Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways
por: Alfaleh, Mohamed A., et al.
Publicado: (2022)

Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
por: Manoochehri, Saeed, et al.
Publicado: (2013)

Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells
por: CHEN, TUNAN, et al.
Publicado: (2015)

Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations
por: Liu, Helong, et al.
Publicado: (2017)

In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
por: Fernandes, Renata S., et al.
Publicado: (2022)

TPGS/hyaluronic acid dual-functionalized PLGA nanoparticles delivered through dissolving microneedles for markedly improved chemo-photothermal combined therapy of superficial tumor
por: Peng, Tingting, et al.
Publicado: (2021)

Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan
por: Mustafa, Sanaul, et al.
Publicado: (2017)

Transferrin-Conjugated Docetaxel–PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle
por: Jose, Sajan, et al.
Publicado: (2019)

The effect of salinomycin on ovarian cancer stem-like cells
por: Chung, Hyewon, et al.
Publicado: (2016)

Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
por: Wang, Qin, et al.
Publicado: (2020)

TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems
por: Farooq, Muhammad Asim, et al.
Publicado: (2022)

Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
por: Cao, Long-Bin, et al.
Publicado: (2016)

Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells
por: Yu, Zuochong, et al.
Publicado: (2018)

Salinomycin as a Drug for Targeting Human Cancer Stem Cells
por: Naujokat, Cord, et al.
Publicado: (2012)

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
por: Li, Jun, et al.
Publicado: (2017)

Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
por: Yang, Conglian, et al.
Publicado: (2018)

Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux
por: Liu, Yajing, et al.
Publicado: (2020)

Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
por: Lee, Hyun-Gyo, et al.
Publicado: (2017)

Targeted delivery of galbanic acid to colon cancer cells by PLGA nanoparticles incorporated into human mesenchymal stem cells
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells
por: Tran, Phuong, et al.
Publicado: (2021)

iTEP Nanoparticle-Delivered Salinomycin Displays an Enhanced Toxicity to Cancer Stem Cells in Orthotopic Breast Tumors
por: Zhao, Peng, et al.
Publicado: (2014)

Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy
por: Norouzi, Mohammad, et al.
Publicado: (2020)

Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles
por: Chen, Dazhong, et al.
Publicado: (2018)

Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition
por: Zhao, Yongmei, et al.
Publicado: (2021)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Synthesis of chemical tools to improve water solubility and promote the delivery of salinomycin to cancer cells
por: Awad, Loay
Publicado: (2020)

Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
por: Huang, Xiaoli, et al.
Publicado: (2016)

The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells
por: Zhang, Yu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ib56lcudveach0fmdttbscad5c